Tag: Merck
Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What...
Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent...
Watch out, Merck: FDA grants Regeneron, Sanofi’s Libtayo priority review for...
One month after Regeneron and Sanofi posted impressive data from a phase 3 trial of their PD-1 inhibitor Libtayo in first-line non-small cell lung...
Merck looks ahead to a COVID drug and vaccine—and a Gardasil...
Merck & Co. is having a decent year, financially speaking. If not for the COVID-19 pandemic, it would be a great one.
The pharma giant...
Merck, Pfizer pneumonia vaccines running low in EU as researchers fight...
As COVID-19 continues to rage worldwide, health authorities worry that a perfect storm of the novel coronavirus, pneumonia and seasonal flu could overtake hospital...
Merck, plagued by limited supply of bladder cancer drug, will build...
During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to...
Eli Lilly, Pfizer, Merck among Big Pharma losers in China’s latest...
Several pharma giants—including Merck, Novartis, Eli Lilly and Pfizer—have just lost procurement deals in China under the country's new bidding system.
The drugmakers lost out to domestic producers, which in some...
Merck, Eisai’s Keytruda-Lenvima combo stonewalled in liver cancer after Roche’s first-in-class...
Tumor response data previously won Merck & Co. and partner Eisai an FDA breakthrough therapy designation for the combination of PD-1 star Keytruda and...
ASCO: Pfizer, Merck KGaA’s Bavencio posts win in rare gynecological cancer
Pfizer and Merck KGaA’s Bavencio is having itself an ASCO. In addition to putting up game-changing results in bladder cancer, it’s posted a win...
With nod in older adults, Merck drives HPV shot Gardasil 9...
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients....
Merck snags national VA contract for its Remicade biosimilar thanks to...
Merck’s Renflexis hasn’t made much of a splash on the market since its FDA approval last April, but the company has now won business...
